Cargando…
Surgical versus Medical Management of Progressive Familial Intrahepatic Cholestasis—Case Compilation and Review of the Literature
(1) Background: Progressive familial intrahepatic cholestasis (PFIC) is a rare cause of liver failure. Surgical biliary diversion (SBD) and ileal bile salt inhibitors (IBAT) can delay or prevent liver transplantation (LTX). A comparison of the two methodologies in the literature is lacking. The comb...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297335/ https://www.ncbi.nlm.nih.gov/pubmed/37371180 http://dx.doi.org/10.3390/children10060949 |
_version_ | 1785063859608879104 |
---|---|
author | Hüpper, Maria Noelle Pichler, Judith Huber, Wolf-Dietrich Heilos, Andreas Schaup, Rebecca Metzelder, Martin Langer, Sophie |
author_facet | Hüpper, Maria Noelle Pichler, Judith Huber, Wolf-Dietrich Heilos, Andreas Schaup, Rebecca Metzelder, Martin Langer, Sophie |
author_sort | Hüpper, Maria Noelle |
collection | PubMed |
description | (1) Background: Progressive familial intrahepatic cholestasis (PFIC) is a rare cause of liver failure. Surgical biliary diversion (SBD) and ileal bile salt inhibitors (IBAT) can delay or prevent liver transplantation (LTX). A comparison of the two methodologies in the literature is lacking. The combination has not been investigated. (2) Methods: We performed a literature survey on medical and surgical treatments for PFIC and reviewed the charts of our patients with PFIC of a tertiary hospital. The end points of our analysis were a decrease in serum bile acid (sBA) levels, reduction of pruritus and delay or avoidance of (LTX). (3) Results: We included 17 case series on SBD with more than 5 patients and a total of 536 patients. External or internal SBD, either conventional or minimally invasive, can reduce pruritus and sBA, but not all PFIC types are suitable for SBD. Six publications described the use of two types of IBAT in PFIC with a total of 118 patients. Treatment response was dependent on genetic type and subtype. Patients with PFIC 2 (nt-BSEP) showed the best response to treatment. Four out of eleven PFIC patients underwent SBD at our centre, with two currently receiving IBAT. (4) Conclusions: Limited data on IBAT in selected patients with PFIC show safety and effectiveness, although surgical methods should still be considered as a successful bridging procedure. Further studies to evaluate a possible combination of IBAT and SBD in PFIC are warranted and treatment decision should be discussed in an interdisciplinary board. |
format | Online Article Text |
id | pubmed-10297335 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102973352023-06-28 Surgical versus Medical Management of Progressive Familial Intrahepatic Cholestasis—Case Compilation and Review of the Literature Hüpper, Maria Noelle Pichler, Judith Huber, Wolf-Dietrich Heilos, Andreas Schaup, Rebecca Metzelder, Martin Langer, Sophie Children (Basel) Review (1) Background: Progressive familial intrahepatic cholestasis (PFIC) is a rare cause of liver failure. Surgical biliary diversion (SBD) and ileal bile salt inhibitors (IBAT) can delay or prevent liver transplantation (LTX). A comparison of the two methodologies in the literature is lacking. The combination has not been investigated. (2) Methods: We performed a literature survey on medical and surgical treatments for PFIC and reviewed the charts of our patients with PFIC of a tertiary hospital. The end points of our analysis were a decrease in serum bile acid (sBA) levels, reduction of pruritus and delay or avoidance of (LTX). (3) Results: We included 17 case series on SBD with more than 5 patients and a total of 536 patients. External or internal SBD, either conventional or minimally invasive, can reduce pruritus and sBA, but not all PFIC types are suitable for SBD. Six publications described the use of two types of IBAT in PFIC with a total of 118 patients. Treatment response was dependent on genetic type and subtype. Patients with PFIC 2 (nt-BSEP) showed the best response to treatment. Four out of eleven PFIC patients underwent SBD at our centre, with two currently receiving IBAT. (4) Conclusions: Limited data on IBAT in selected patients with PFIC show safety and effectiveness, although surgical methods should still be considered as a successful bridging procedure. Further studies to evaluate a possible combination of IBAT and SBD in PFIC are warranted and treatment decision should be discussed in an interdisciplinary board. MDPI 2023-05-26 /pmc/articles/PMC10297335/ /pubmed/37371180 http://dx.doi.org/10.3390/children10060949 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Hüpper, Maria Noelle Pichler, Judith Huber, Wolf-Dietrich Heilos, Andreas Schaup, Rebecca Metzelder, Martin Langer, Sophie Surgical versus Medical Management of Progressive Familial Intrahepatic Cholestasis—Case Compilation and Review of the Literature |
title | Surgical versus Medical Management of Progressive Familial Intrahepatic Cholestasis—Case Compilation and Review of the Literature |
title_full | Surgical versus Medical Management of Progressive Familial Intrahepatic Cholestasis—Case Compilation and Review of the Literature |
title_fullStr | Surgical versus Medical Management of Progressive Familial Intrahepatic Cholestasis—Case Compilation and Review of the Literature |
title_full_unstemmed | Surgical versus Medical Management of Progressive Familial Intrahepatic Cholestasis—Case Compilation and Review of the Literature |
title_short | Surgical versus Medical Management of Progressive Familial Intrahepatic Cholestasis—Case Compilation and Review of the Literature |
title_sort | surgical versus medical management of progressive familial intrahepatic cholestasis—case compilation and review of the literature |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297335/ https://www.ncbi.nlm.nih.gov/pubmed/37371180 http://dx.doi.org/10.3390/children10060949 |
work_keys_str_mv | AT huppermarianoelle surgicalversusmedicalmanagementofprogressivefamilialintrahepaticcholestasiscasecompilationandreviewoftheliterature AT pichlerjudith surgicalversusmedicalmanagementofprogressivefamilialintrahepaticcholestasiscasecompilationandreviewoftheliterature AT huberwolfdietrich surgicalversusmedicalmanagementofprogressivefamilialintrahepaticcholestasiscasecompilationandreviewoftheliterature AT heilosandreas surgicalversusmedicalmanagementofprogressivefamilialintrahepaticcholestasiscasecompilationandreviewoftheliterature AT schauprebecca surgicalversusmedicalmanagementofprogressivefamilialintrahepaticcholestasiscasecompilationandreviewoftheliterature AT metzeldermartin surgicalversusmedicalmanagementofprogressivefamilialintrahepaticcholestasiscasecompilationandreviewoftheliterature AT langersophie surgicalversusmedicalmanagementofprogressivefamilialintrahepaticcholestasiscasecompilationandreviewoftheliterature |